President Trump is set to unveil new initiatives Tuesday aimed at reducing US drug costs. These include a "TrumpRx" website for discounted direct-to-consumer medicine purchases and a potential deal with Pfizer. The effort revives his "Most Favored Nation" policy, pushing for domestic prices to match those in peer countries. This comes amid ongoing pressure on drugmakers, with Trump threatening consequences for non-compliance and advocating for direct purchase channels, while industry groups warn of potential ramifications.

Prepared by Lauren Mitchell and reviewed by editorial team.